Clinical Investigation of Patient Outcomes after IOL Implantation with Different IOL Delivery Systems

Clinical Investigation of Patient Outcomes after IOL Implantation with Different IOL Delivery Systems - ILT142-P001

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00020134

Enrollment

Registered

2020-03-12

Start date

2020-09-04

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

H26.9

Interventions

Group 1: Alcon Clareon aspheric hydrophobic acrylic IOL (intraocular lens) with the AutonoMe automated pre-loaded delivery system (Model´CNA0T0) Group 2: Hoya Vivinex iSert Delivery system pre-loaded

Eligibility

Sex/Gender

All

Age

22 Years to No maximum

Inclusion criteria

Inclusion criteria: - Adults, 22 years of age or older, diagnosed with bilateral cataracts grades - Planned small incision cataract removal surgery - Preoperative corneal astigmatism < 1.50 D in both eyes Other protocol-defined inclusion criteria may apply.

Exclusion criteria

Exclusion criteria: - Previous or planned refractive surgery during the subject’s participation in the study - Previous corneal transplant - Rubella, congenital, traumatic, or complicated - Any subject currently participating in another investigational drug or device study that may confound the results of this investigation. Other protocol-defined exclusion criteria may apply.

Design outcomes

Primary

Measure	Time frame
Mean monocular distance BCDVA at 1 month after cataract surgery.	—

Countries

Germany, United Kingdom

Contacts

Public ContactCDMA Project Lead

Alcon Research, LLC

alcon.medinfo@alcon.com+1-888-451-3937

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026